Bridging continual reassessment method for phase I clinical trials in different ethnic populations

E-ISSN： 1097-0258|34|10|1681-1694

ISSN： 0277-6715

Source： STATISTICS IN MEDICINE, Vol.34, Iss.10, 2015-05, pp. : 1681-1694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bayesian optimal interval designs for phase I clinical trials

JOURNAL OF THE ROYAL STATISTICAL SOCIETY: SERIES C (APPLIED STATISTICS), Vol. 64, Iss. 3, 2015-04 ,pp. : 507-523

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Bayesian dose‐finding design for phase I/II clinical trials with nonignorable dropouts

STATISTICS IN MEDICINE, Vol. 34, Iss. 10, 2015-05 ,pp. : 1721-1732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical utility estimation for assay cutoffs in early phase oncology enrichment trials

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 3, 2015-05 ,pp. : 233-341

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose finding with continuous outcome in phase I oncology trials

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 2, 2015-03 ,pp. : 102-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bayesian methods for setting sample sizes and choosing allocation ratios in phase II clinical trials with time‐to‐event endpoints

STATISTICS IN MEDICINE, Vol. 34, Iss. 11, 2015-05 ,pp. : 1889-1903

John Wiley & Sons Inc

Access to resources Recommend Favorite